Impact of oral semaglutide on cardiovascular risk factors in patients with type 2 diabetes and atherosclerotic cardiovascular disease and/or chronic kidney disease: a SOUL post hoc analysis
30 August 2025 (08:33 - 08:51)
Organised by: 
About the speaker
Dalhousie University, Halifax (Canada)
4 More presentations in this session
Professor D. Bhatt (New York City, US)
Doctor R. Aggarwal (Boston, US)
Professor I. Gouni-Berthold (Cologne, DE)
Doctor D. Bhatt (New York City, US)
Access the full session
The Event
ESC Congress 2025
30 August 2025
08:33 CET
You may be interested in
Congress Session
